Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity

Arterioscler Thromb. 1994 Jan;14(1):47-53. doi: 10.1161/01.atv.14.1.47.

Abstract

T lymphocytes, macrophages, and oxidized low-density lipoprotein (Ox-LDL) are collocalized in early atherosclerotic lesions. Using a low-endotoxin in vitro system, we observed that Ox-LDL but not native LDL induced the production, by both freshly adherent human peripheral blood monocytes and human monocytic THP-1 cells, of the alpha chemokine interleukin (IL)-8, a potent chemoattractant for T lymphocytes. Marked IL-8 induction by Ox-LDL did not require IL-1 beta generation in THP-1 cells. Ox-LDL-induced chemokine production was selective, as Ox-LDL did not stimulate the production by THP-1 cells of the T-lymphocyte chemotactic beta chemokine macrophage inflammatory protein (MIP)-1 alpha. IL-8 induction increased in proportion to the extent of oxidation of LDL as measured by the content of lipid oxidation end products. To identify potentially active components of Ox-LDL, we tested malondialdehyde, an arachidonate-derived lipid oxidation product, and 9-hydroxyoctadecadienoic acid, an oxidation product of linoleate, the major polyunsaturated fatty acid in LDL, and observed that they induced IL-8 generation in the absence of Ox-LDL. Furthermore, when most free lipid oxidation products were removed from Ox-LDL by dialysis, some IL-8-inducing activity was released into the dialysate. However, the major IL-8-inducing activity was not dialyzable. To address the nature of the LDL particle modification required to induce IL-8, acetylated or malondialdehyde-treated native LDL particles were monitored for activity. Neither procedure rendered LDL capable of inducing IL-8. However, phospholipase A2-treated LDL induced THP-1 cell expression of IL-8.(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acetylation
  • Chemotaxis, Leukocyte*
  • Humans
  • Interleukin-1 / biosynthesis
  • Interleukin-8 / biosynthesis*
  • Leukemia, Myeloid
  • Linoleic Acids / pharmacology
  • Linoleic Acids, Conjugated*
  • Lipoproteins, LDL / pharmacology*
  • Malondialdehyde / pharmacology
  • Monocytes / drug effects
  • Monocytes / metabolism*
  • Oxidation-Reduction
  • Phospholipases A / pharmacology
  • Phospholipases A2
  • T-Lymphocytes / physiology*
  • Thiobarbituric Acid Reactive Substances / metabolism
  • Tumor Cells, Cultured

Substances

  • Interleukin-1
  • Interleukin-8
  • Linoleic Acids
  • Linoleic Acids, Conjugated
  • Lipoproteins, LDL
  • Thiobarbituric Acid Reactive Substances
  • 9-hydroxy-10,12-octadecadienoic acid
  • Malondialdehyde
  • Phospholipases A
  • Phospholipases A2